E. Szabados et al., Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia-reperfusion in perfused rat heart, FREE RAD B, 27(9-10), 1999, pp. 1103-1113
Poly-ADP-ribose polymerase (PARP) is considered to play an important role i
n oxidative cell damage. We assumed that ischemia-reperfusion resulting fro
m the increasing reactive oxygen species (ROS) can lead to the activation o
f endogenous mono- and poly-ADP-ribosylation reactions and that the reducti
on of ROS level by Lipoamide, a less known antioxidant, can reverse these u
nfavorable processes. Experiments were performed on isolated Langendorff he
arts subjected to 60-min ischemia followed by reperfusion. ROS, malondialde
hyde, deoxyribonucleic acid (DNA) breaks, and NAD(+) content were assayed i
n the hearts, and the ADP-ribosylation of cytoplasmic and nuclear proteins
were determined by Western blot assay. Ischemia-reperfusion caused a modera
te (30.2 +/- 8%) increase in ROS production determined by the dihydrorhodam
inel23 method and significantly increased the malondialdehyde production (f
rom <1 to 23 +/- 2.7 nmol/ml), DNA damage (undamaged DNA decreased from 71
+/- 7% to 23.1 +/- 5%), and NAD(+) catabolism. In addition, ischemia-reperf
usion activated the mono-ADP-ribosylation of GRP78 and the self-ADP-ribosyl
ation of the nuclear PARP. The perfusion of hearts with lipoamide significa
ntly decreased the ischemia reperfusion-induced cell membrane damage determ
ined by enzyme release (LDH, CK, and GOT), decreased the ROS production, re
duced the malondialdehyde production to 5.5 +/- 2.4 nmol/ml, abolished DNA
damage, and reduced NAD(+) catabolism. The ischemia-reperfusion-induced act
ivation of poly- and mono-ADP-ribosylation reactions were also reverted by
lipoamide. In isolated rat heart mitochondria, dihydrolipoamide was found t
o be a better antioxidant than dihydrolipoic acid. Ischemia-reperfusion by
ROS overproduction and increasing DNA breaks activates PARP leading to acce
lerated NAD(+) catabolism, impaired energy metabolism, and cell damage. Lip
oamide by reducing ROS levels halts PARP activation and membrane damage and
improves the recovery of postischemic myocardium. (C) 1999 Elsevier Scienc
e Inc.